Tag: ABCSG 62
Enrollment target reached for the ABCSG 62 / CAMBRIA-2 trial
11.08.2026
The international phase III ABCSG 62 / CAMBRIA-2 trial has reached an important milestone: The enrollment target of 5,500 patients was achieved as planned in June 2026. By the official end of recruitment on July 1, 2026, a total of 5,511 patients has been enrolled in the trial.
read more
ABCSG 62 / CAMBRIA-2: FIRST PATIENT IN at the University Clinic for Gynecology Innsbruck
03.05.2024
Just two weeks ago, the Pyhrn-Eisenwurzen Clinic Steyr was the first center in Austria to be activated for the ABCSG 62 / CAMBRIA-2 trial. Now, on May 3rd, the Clinical Department of Gynecology and Obstetrics at the University Clinic for Gynecology in Innsbruck was able to enroll the first patient (FPI) within the COOP network, […]
read moreShare on